Claritev Q2 Revenue, EBITDA Crush Estimates; 2026 Outlook Raised
CTEV has more than doubled off its 52-week low of $11.5.
Summary
Claritev delivered a strong Q2 beat across key metrics: revenue of $257.48M topped consensus by 5.2%, adjusted EBITDA of $155.80M beat by 6%, and operating income of $23.41M nearly tripled the $8.70M estimate. The company raised full-year 2026 guidance, now targeting $1B-$1.02B in revenue and $610M-$620M in adjusted EBITDA, with free cash flow of $5M-$15M. This follows the DOJ antitrust probe closure in June, removing a major overhang. The results validate management's strategy of portfolio expansion and TPA market bookings, signaling a return to growth after a net loss of $73.56M in Q1. With shares at $26.84 and a median analyst target of $37.50, the guidance raise could drive further re-rating.
At the time of this announcement, CTEV was trading at $26.84 on NYSE in the Trade & Services sector, with a market capitalization of approximately $457.6M. The 52-week trading range was $11.50 to $74.07. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.